RÉSUMÉ
<p><b>OBJECTIVE</b>To explore the expressions of P33ING1, P53 and their relationships with apoptosis in anal canal carcinoma (ACC).</p><p><b>METHODS</b>The expressions of P33ING1, P53 proteins were measured by immunohistochemistry method (SP method), and apoptosis was detected in 42 cases with ACC, 36 cases with anal canal adenoma (ACA) or anal canal papilloma (ACP), and 40 cases with paraanal inflammatory mass(PAIM).</p><p><b>RESULTS</b>The positive expression rates of P33ING1 and P53 proteins were 40.5% (17/42), 97.2% (35/36) and 97.5% (39/40), 50.0% (21/42), 22.2% (8/36) and 27.5% (11/40) respectively, and the average apoptosis indexes(AI) were (10.27+/- 1.23) per thousand, (42.75+/- 0.98) per thousand and (42.67+/- 1.04) per thousand respectively in ACC, ACA or ACP and PAIM. There were significant differences in the positive expression rates of P33ING1, P53 and apoptosis index between ACC and the other two groups respectively (P< 0.05). Among 21 cases of ACC with positive expression of P53 protein,there were 18 cases with P33ING1 negative expression.</p><p><b>CONCLUSIONS</b>P33ING1 expression decrease in ACC, which may play an important role in the carcinogenesis and progression of ACC. P33ING1 and P53 may have an synergistic effect of suppressing cell growth and accelerating cell apoptosis.</p>
Sujet(s)
Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Femelle , Humains , Mâle , Adulte d'âge moyen , Tumeurs de l'anus , Métabolisme , Anatomopathologie , Apoptose , Carcinomes , Métabolisme , Anatomopathologie , Immunohistochimie , Protéine-1 d'inhibition de croissance , Protéines et peptides de signalisation intracellulaire , Métabolisme , Stadification tumorale , Protéines nucléaires , Métabolisme , Protéine p53 suppresseur de tumeur , Métabolisme , Protéines suppresseurs de tumeurs , MétabolismeRÉSUMÉ
<p><b>OBJECTIVE</b>To summarize the clinicopathological characteristics of primary anorectal malignant melanoma (AMM).</p><p><b>METHODS</b>Clinical data of nine patients with AMM were reviewed retrospectively from January 1999 to March 2005.</p><p><b>RESULTS</b>Anorectal malignant melanoma had a female predominance. The average age was 56 years old and average course of disease was 5.8 months. The onset of symptom was hematochezia, then anus prolapses. 94.7% of patients had AMM within 5 cm from anus margin; the average tumor size was (3.3+/- 2.1) cm. The polyp and ulcer were most common types. More than a half (54.5%) of the tumor was movable, 19.1% smooth surfaced, 6.6% soft textured. Synchronous metastasis was found in 14.0% of the patients, the first common metastasis was found in liver, the secondary was superficial inguinal lymph node metastasis. Half of the patients were misdiagnosed,and over 50% of patients were misdiagnosed as benign disease. Mile's operation was performed in most of patients (63%), while anal resection was performed in 30% of the patients.</p><p><b>CONCLUSIONS</b>Anorectal malignant melanoma is often misdiagnosed,surgical procedure is the first choice for patients with AMM.</p>